PLD
40
5
EMC
52
3
FOX
71
9
JBHT
45
3
LOW
59
4
AMG
79
2
AES
49
2
AMGN
25
2
HOG
57
7
LEG
48
5
ACN
42
6
AAL
45
-2
PPG
54
6
ROST
70
3
AEP
72
3
UNP
32
3
ORLY
60
2
ROK
54
-6
MAS
82
4
GPC
69
3
PLD
40
5
EMC
52
3
FOX
71
9
JBHT
45
3
LOW
59
4
AMG
79
2
AES
49
2
AMGN
25
2
HOG
57
7
LEG
48
5
ACN
42
6
AAL
45
-2
PPG
54
6
ROST
70
3
AEP
72
3
UNP
32
3
ORLY
60
2
ROK
54
-6
MAS
82
4
GPC
69
3
Financhill
Back

Candel Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61

CADL
Candel Therapeutics

Last Price:
$6.05
Seasonality Move:
-11.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Candel Therapeutics Stock Forecast

  • Over the next 52 weeks, Candel Therapeutics has on average historically risen by 69.5% based on the past 4 years of stock performance.
  • Candel Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Candel Therapeutics Stock Undervalued?
    The current Candel Therapeutics [CADL] share price is $6.40. The Score for CADL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • CADL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Candel Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Candel Therapeutics has on average historically risen by 69.5% based on the past 4 years of stock performance.

Candel Therapeutics Stock Rating

Buy
61
Candel Therapeutics (CADL) is a Buy

Is Candel Therapeutics overpriced?

  • Candel Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Candel Therapeutics Stock Price History

Is CADL stock going to rise?

  • The current trend is moderately bearish and CADL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
candeltx.com

52-Week Data

52-Week High:
14.60
52-Week Low:
3.79

Prediction Charts

Market Cap:
341.3M
Price in USD:
6.40
Volume:
862.6K
Beta:
-0.90

Technical Analysis

SMA50:
5.85
SMA100:
5.63
SMA200:
6.37
52-Wk Change:
9.59%

Stock Predictions

  • Is Candel Therapeutics stock public?
    Yes, Candel Therapeutics is a publicly traded company.
  • What is the Candel Therapeutics stock quote today?
    The Candel Therapeutics stock price is 6.40 USD today.
  • How to buy Candel Therapeutics stock online?
    You can buy Candel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-25 6.97 7.02 7.04 6.74
Jul-28 6.98 6.86 7.00 6.76
Jul-29 6.87 6.57 6.95 6.35
Jul-30 6.50 6.57 6.93 6.47
Jul-31 6.42 6.45 6.69 6.34
Aug-1 6.30 6.29 6.34 6.11
Aug-4 6.31 6.31 6.40 6.17
Aug-5 6.37 6.17 6.38 6.08
Aug-6 6.15 5.96 6.18 5.90
Aug-7 6.03 5.84 6.04 5.74
Aug-8 5.84 6.02 6.04 5.84
Aug-11 6.05 6.21 6.37 6.00
Aug-12 6.21 6.35 6.43 6.12
Aug-13 6.28 6.40 6.48 6.11

Candel Therapeutics Earnings

Candel Therapeutics Earnings Report: Per Share Candel Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Candel Therapeutics Forecast Revenue Growth

Candel Therapeutics Stock Analysis: Historical quarterly revenues per share for Candel Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.03 per share.

* Candel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.